Dr Cheryl Ann Ferrier, MD | |
3131 Mount Vernon Ave, 4a/b, Alexandria, VA 22305-2640 | |
(703) 739-8888 | |
(703) 519-8728 |
Full Name | Dr Cheryl Ann Ferrier |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 31 Years |
Location | 3131 Mount Vernon Ave, Alexandria, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750467692 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 0101057586 (Virginia) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Privia Medical Group Llc | 4385682061 | 1176 |
News Archive
Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.
A recent study shows that mutated SARS-CoV-2 strains with a substitution at position 501 might have circulated unnoticed even before the end of September 2020, when the rapid emergence of B.1.1.7 lineage (carrying the N501Y mutation) was initially reported.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a National Institutes of Health-supported randomized controlled clinical trial.
› Verified 2 days ago
Entity Name | Privia Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20050422000298 |
News Archive
Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.
A recent study shows that mutated SARS-CoV-2 strains with a substitution at position 501 might have circulated unnoticed even before the end of September 2020, when the rapid emergence of B.1.1.7 lineage (carrying the N501Y mutation) was initially reported.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a National Institutes of Health-supported randomized controlled clinical trial.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Cheryl Ann Ferrier, MD 3131 Mount Vernon Ave, 4a/b, Alexandria, VA 22305-2640 Ph: (703) 739-8888 | Dr Cheryl Ann Ferrier, MD 3131 Mount Vernon Ave, 4a/b, Alexandria, VA 22305-2640 Ph: (703) 739-8888 |
News Archive
Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.
A recent study shows that mutated SARS-CoV-2 strains with a substitution at position 501 might have circulated unnoticed even before the end of September 2020, when the rapid emergence of B.1.1.7 lineage (carrying the N501Y mutation) was initially reported.
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
Men with hormone-sensitive metastatic prostate cancer who received the chemotherapy drug docetaxel given at the start of standard hormone therapy lived longer than patients who received hormone therapy alone, according to early results from a National Institutes of Health-supported randomized controlled clinical trial.
› Verified 2 days ago
Dr. Kenneth Michael Ahdoot, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4660 Kenmore Ave, Suite #902, Alexandria, VA 22304 Phone: 703-370-4300 Fax: 703-370-0044 | |
Ms. Andrea Ellen Williams, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 700 S Washington St Ste 330, Alexandria, VA 22314 Phone: 703-940-3364 Fax: 703-717-4055 | |
Lalitha S Rambhala, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2 E Glebe Rd, Alexandria, VA 22305 Phone: 703-535-5568 Fax: 703-535-1583 | |
Dr. Tina Tonga Pham, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6355 Walker Ln, 408, Alexandria, VA 22310 Phone: 703-719-5901 Fax: 703-719-9629 | |
Dr. Kristina Kathleen Hibshman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4660 Kenmore Ave, Suite 1100, Alexandria, VA 22304 Phone: 703-370-0400 | |
Lauren Michelle Gover, APRN, CNM Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4660 Kenmore Ave Ste 902, Alexandria, VA 22304 Phone: 703-370-4300 Fax: 703-832-0050 | |
Alexis D Light, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 700 S Washington St Ste 330, Alexandria, VA 22314 Phone: 703-940-3364 Fax: 703-717-4055 |